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An investigation of factors limiting aerobic capacity 
in patients with ankylosing spondylitis 
R. CARTER*, I? RIANTAWAN”, S. W. BANHAM* AND R. D. STURROCK~ 
*Department of Respiratory Medicine and +Centre For Rheumatic Diseases, Royal Infirmay, Glasgow, U.K. 
Ankylosing spondylitis (AS) has been shown to produce exercise limitation and breathlessness. The purpose of this 
study was to investigate factors which may be responsible for limiting aerobic capacity in patients with AS. 
Twenty patients with no other cardio-respiratory disease performed integrative cardiopulmonary exercise testing 
(CPET). The results were compared to 20 age and gender matched healthy controls. Variables that might influence 
exercise tolerance, including pulmonary function tests (body plethysmography), respiratory muscle strength (MIP, 
MEP) and endurance (Tlim), AS severity assessment including chest expansion (CE), thoracolumber movement 
(TL), wall tragus distance and peripheral muscle strength assessed by maximum voluntary contraction of the knee 
extensors (Qds), hand grip strength and lean body mass (LBM), were measured in the patients with AS and used as 
explanatory variables against the peak 90, achieved during CPET. 
AS subjects achieved a lower peak VO, than controls (252+ 1.4 vs. 33.1 k1.6 ml kgg’min-‘, rnean+~~~, 
P=O.OOl). When compared with controls, ventilatory response (?n/6C02) in AS was elevated (P=O.Ol); however 
gas exchange indices, transcutaneous blood gases and breathing reserve were similar to controls. AS subjects 
developed a higher HR/V02 response (P<O.Ol) on exertion but without associated abnormalities in ECG, blood 
pressure response or anaerobic threshold. The AS group experienced a greater degree of leg fatigue (P < 0.01) than 
controls at peak exercise. Although the breathlessness scores (BS) were comparable to controls at peak exercise, the 
slopes of the relationship between BS and work rate (WR) [AS 0.054 (0. l), Controls 0.043 (0.06); P < 0.051 and BS 
and % predicted oxygen uptake [AS 0.084 (0.18), Controls 0.045 (0.06); P<O.Ol] were steeper in the AS subjects. 
There was weak association between peak VO, and vital capacity (r2% 12.0), MIP (11.8) but no association 
between Tlim, CE, Wall tragus distance or TL movement. The strongest association with aerobic capacity was 
between measurements of peripheral muscle strength (Qds; r=0.75 ; hand grip; r=0.47) accounting for 53% 
(P<O.OOl) and 23.5% (P<O.Ol)of the total variance in peak V02, respectively. The addition of LBM to Qds in the 
regression model significantly improved the explained variance to 783% (P<O.OOl). 
This study shows that peripheral muscle function is the most important determinant of exercise intolerance in AS 
patients suggesting that deconditioning is the main factor in the production of the reduced aerobic capacity. 
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Introduction 
Ankylosing spondylitis (AS) is a chronic inflammatory 
arthropathy characterized by progressive stiffness and 
eventual fusion of the axial skeleton. A restrictive ventilatory 
defect has been extensively reported (l-6) in association with 
this condition but the relationship of the musculo-skeletal 
limitations and pulmonary impairment in affecting exercise 
tolerance has not been extensively investigated. Grimby et al. 
reported that four out of eight patients with AS complained 
of breathlessness on exertion (7) and in a study by Elliot et 
Received 24 February 1999 and accepted in revised form 8 June 
1999. 
Correspondence should be addressed to: Roger Carter, Principal 
Clinical Scientist, Department of Respiratory Medicine, Queen 
Elizabeth Building, Royal Infirmary, Alexandra Parade, Glasgow, 
G31 2ES, U.K. 
0954-6111/99/100700+09 $12*00/O 
al. there was significant reduction in exercise capacity of 6 
patients with AS when compared to age matched controls 
and this was attributed to deconditioning or cardiovascular 
impairment (8). Anthropometric or musculoskeletal factors, 
as well as pulmonary function abnormalities, contribute to 
exercise intolerance but the relative contribution of these 
factors to the reduction of aerobic capacity in AS patients 
has not been quantitatively examined. Improved knowledge 
in this area would be of clinical importance, both in 
understanding the pathophysiological basis of exercise 
limitation and devising effective training/rehabilitation stra- 
tegies for sufferers of this condition. 
The object of the present study was to identify and 
determine the individual and additive influence of respira- 
tory variables, AS severity and general fitness/decondition- 
ing on overall aerobic power, as assessed by maximal 
oxygen uptake during an integrative cardiopulmonary 
exercise test in AS patients. 
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Patients and methods 
PATIENT POPULATION 
Twenty patients (13 male/7 female; mean age 46.5 SD 11.6 
years) with definite AS (modified New York criteria) (9) 
were recruited from a tertiary referral AS Clinic. The 
recruitment was carried out with no reference to the 
presence of respiratory symptoms or exercise/smoking 
habits. Patients with a history of cardiac disease or taking 
beta-blockers, patients with exposure to radiation, asbestos 
or drugs associated with pneumonitis and patients with 
chest pain on deep inspiration were excluded, as were 
patients with significant pain in the hip, knee or ankle joints 
or with hip replacement precluding optimal exercise 
performance. Twenty age and gender matched healthy 
volunteers served as controls. Written informed consent 
was obtained from each subject prior to testing and the 
study was approved by the hospital ethics committee. 
AS SEVERITY 
Chest expansion was measured circumferentially around 
the chest wall at the level of the fourth intercostal space 
with the subject standing with hands on head and arms 
flexed in the frontal plane (18). The total range of the 
thoracolumber (TL) movement in the sagital plane was 
measured using a spondylometer and expressed as degrees 
(19). Wall tragus distance was used as an index of thoracic 
kyphosis and expressed in centimetres. 
PULMONARY FUNCTION TESTING 
Lung volumes and specific airways conductance (SG,,) 
were measured using a constant volume body plethysmo- 
graph (PK Morgan, Rainham, U.K.). The highest value 
obtained from three technically acceptable manoeuvres was 
reported as the vital capacity (VC). Mean values of thoracic 
gas volume (TGV), total lung capacity (TLC), and specific 
airway conductance (SG,,) were calculated from three 
technically satisfactory tests. Transfer factor for carbon 
monoxide was measured by the modified single breath 
technique (10) using a validated Transflow System (PK 
Morgan) (11). All procedures were performed in accor- 
dance with guidelines recommended by the British Thoracic 
Society and the Association of Respiratory Technicians and 
Physiologists (12). Standard reference values for lung 
volumes (13) conductance, and transfer factor (DL,,) were 
used (14). In AS subjects, the calculation of predicted 
values was based on the height prior to the onset of disease 
where this was reliable, or on arm span measurements. 
Maximum voluntary ventilation was measured over 15 s 
using the pneumotachometer of the plethysmograph 
system. Each subject produced three efforts separated by 
a minimum of 3 min for recovery. The highest value was 
chosen for the subsequent calculation of the breathing 
reserve (BR) by the formula: 
BR% = [l - Vzmax/MVV] x 100 
RESPIRATORY MUSCLE FUNCTION AND 
ENDURANCE 
Maximal inspiratory pressure, at functional residual 
capacity volume and expiratory pressure at total lung 
capacity were measured using a digital mouth pressure 
meter (Precision Medical, York, U.K.). This equipment has 
been shown to provide reliable and accurate measures of 
maximum respiratory pressures in normal subjects and in 
patients with respiratory disorders (15). A minimum of five 
efforts were made for each manoeuvre until three readings 
were obtained within 10%. The highest reading was taken 
to reflect peak pressure. 
Respiratory muscle endurance was assessed using an 
assisted breathing protocol (16,17). The subject, with a 
noseclip in place, sat and breathed through a resistive 
training device (Pflex, Health Scan, U.S.A.) incorporating 
six adjustable alinear inspiratory orifices and a one-way 
expiratory valve. Mouth pressure was continuously dis- 
played on an oscilloscope for visual feedback via a 
differential pressure transducer connected to the mouth- 
piece of the resistive training device. The subject was 
instructed to inspire and expire according to the sound 
signal generated from an electrical metronome. Inspiratory 
duration (Ti) was set at 1.7 s and total breath duration 
(Ttot) at 2.6 s, producing a duty cycle (Ti/Ttot) of 0.4 and a 
breathing frequency of 14 mini. A square wave and target 
line were set on the oscilloscope screen and the subject was 
encouraged to maintain the required breathing pattern and 
target pressure for as long as possible. During testing the 
target pressure was set at 70% of MIP. The subject was 
encouraged to maintain the target pressure on the breathing 
pattern. Endurance time was defined as the moment at 
which the subject was unable to maintain the target 
pressure for three consecutive breaths. 
PERIPHERAL MUSCLE FUNCTION 
Peripheral muscle function was assessed by measuring both 
muscle strength (Knee extensors and hand grip) and 
amount (lean body mass). The force of the maximum 
voluntary contraction of the knee extensors was measured 
by the method described by Edwards et al. (20). The subject 
sat upright in an adjustable straight-backed chair with the 
lower leg dependent and the knee flexed to 90”. A cuff was 
placed round the leg just proximal to the maleolar and 
attached horizontally to an electrical strain gauge (Cranley 
and Co., U.K.) with a digital readout. The subjects 
performed three maximal voluntary contractions at ap- 
proximately 1 min intervals. The greatest peak force 
achieved was recorded. Peak tort was calculated from the 
product of four and the distance between mid-knee joint 
and mid-point of the lower leg strap, and was expressed in 
Newton-metre (N-m). Since the quadriceps femorus is the 
principle muscle engaged in knee extension the maximal 
force is abbreviated to Qds (21). 
Right hand grip strength was measured using a hand- 
held dynometer (Takei Company, Japan) with digital 
readout. Peak grip strength was recorded from the 
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maximum of three efforts separated by 1 min intervals and 
expressed in kilogram watts (kgw). Lean body mass (LBM) 
was calculated from the sum of skinfold thicknesses at four 
sites, namely biceps, triceps, subscapula and superiliac 
regions as described by Durning et al. (22) and expressed in 
kilograms. 
CARDIOPULMONARY EXERCISE TESTING 
Symptom limited exercise tests (CPET) were performed 
using an electrically braked bicycle ergometer (CardioKi- 
netics Ltd, Salford, U.K.) with the subject breathing 
through a low dead space, low resistance valve box. The 
valve box incorporates a flexible pneumotachograph system 
in the mouth-piece assembly (Flexiflow, PK Morgan, 
Rainham, U.K.) for the measurement of minute ventila- 
tion. The expired limb is fed through a mixing chamber 
from which samples of expired gas are analysed for the 
fractional concentrations of carbon dioxide and oxygen 
using an infrared spectrometer and fuel cell/zirconium 
analyser, respectively (Benchmark Exercise System, PK 
Morgan). The gas analysers were calibrated with certified 
gas mixtures and the pneumotachograph system was 
verified using a 3 1 syringe before each exercise test. 
Throughout each test, minute ventilation #E), oxygen 
consumption @OS), and carbon dioxide production 
(i7C02) were measured by on-line ventilation and expired 
gas analysis using standard equations (23). The ventilatory 
anaerobic threshold on exertion was calculated by the curve 
fitting method using a plot of *O, against *CO* (24). 
Transcutaneous oxygen (t&02) and carbon dioxide 
(tcPCO3 tensions were monitored using a combined heated 
electrode (TINA, Radiometer Ltd, Copenhagen, Denmark) 
and its monitoring system (TCM3) after an in tivo 
calibration using an arterialized ear lobe capillary sample. 
This system has been validated against blood sampled 
directly from an arterial canmda during exercise in our 
laboratory (25-27) and has been shown to provide a 
reliable non-invasive assessment of gas exchange during 
exercise. The transcutaneous values and mixed expired gas 
values were used to derive the dead space ventilation to 
tidal volume ratio (V,/V-r) and the alveolar-arterial oxygen 
gradient (AaO,) using standard formulae (23). 
Subjects were initially monitored for 2 min at rest whilst 
seated on the bicycle ergometer. They were then instructed 
to cycle with no additional load for 2 min. Thereafter the 
workload was increased by increments of 25 watts every 
2 min and the subjects were encouraged to continue 
exercising until they could no longer sustain the desired 
pedalling frequency of 50 rpm. Exercise variables including 
transcutaneous values were measured or averaged over the 
last 30 s of each workload and at peak exercise. Exercise 
parameters were compared with the reference values of 
Jones et al. (28). The modified Borg category Scale (29) was 
used to rate the intensity of breathlessness and leg fatigue. 
An explanation of the scale was given prior to the tests and 
the scale was positioned in front of the subject. The subject 
was instructed to give a breathlessness score (BS) at the end 
of each workload and at peak exercise where, in addition, a 
leg fatigue score was elicited (LS). BS values so obtained 
allowed the changes in magnitude of breathlessness in 
relation to work rate (WR) and oxygen uptake expressed as 
percent predicted maximum (irO*%) to be examined. The 
slopes of ABS/AV02% and ABS/AWR were expressed as 
means of slope from linear regression analysis of each 
subject’s data. 
STATISTICAL METHODS 
Descriptive data are presented as mean+ standard devia- 
tion (SD). Comparisons between the normal and AS subjects 
were performed using unpaired Student’s t-tests for 
continuous variables. Simple linear regression and Spear- 
man correlation coefficients were used to assess the 
relationship between peak QO, and other variables. The 
additive influence of explanatory variables and peak \iO, 
was examined using forward step-wise regression analysis. 
The proportion of variance accounted for by each relation- 
ship is reported as ?, expressed as a percentage. Level of 
probability was calculated from F or partial F values and 
statistical significance was assessed at the 5% level. A 
Minitab statistical package (Minitab Inc., U.S.A.) was used 
for data analysis. 
Results 
The AS subjects exhibited a range of functional impairment 
and degree of spinal mobility. Chest expansion was 2.02 
ems ( f 0.7 l), thoracolumber movement measured in the 
sagital plane was 51.4( & 17.7)% and wall tragus distance as 
an index of thoracic kyphosis was 16.9(-t 6.1) ems. 
Patient demographic data and pulmonary function tests 
in comparison with the control group are presented in 
Table 1. VC and TLC were significantly smaller in the AS 
group averaging 78% and 86% of predicted, respectively 
(P<O@l). There was no significant difference between 
other parameters of lung function in AS subjects as 
compared to controls. In comparison with the control 
group there was no significant difference in measures of 
respiratory muscle strength although respiratory muscle 
endurance measurements were significantly shorter in AS 
subjects [Mean Tlim 130 (116) s] compared to controls 
[Tlim 258 (106); P<O.Ol]. Static peripheral skeletal muscle 
strength was significantly lower in the patients with AS than 
in the control subjects [Qds 69.5 (22.9) vs. 95.1 (15.6); 
PC O-01: Handgrip strength, kgW 35.3 (11.7) vs. 42.7 ( 9.9); 
P e O-05; respectively]. 
AEROBIC CAPACITY AND SYMPTOMS 
Exercise data and modified Borg Scores for the AS subjects 
and controls is presented in Table 1. AS subjects achieved a 
lower work capacity averaging 123 watts compared with 
148 watts in controls (P=O.Ol). Peak 60, was significantly 
lower in the AS group with a mean of 25.2+ 1.4 (75% 
predicted) compared to 33.1k1.6 ml kg-’ min-’ in the 
controls. The majority of the subjects in both groups ceased 
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TABLE 1. Comparison of baseline data and peak exercise values between Ankylosing Spondyhtis (AS) and control subjects 
Age, years 
Gender, male:female 
Smokers: non-smokers 
Heigh, cm 
Weight, kg 
VC, % predicted 
FRC, % predicted 
RV, % predicted 
TLC, % predicted 
SGaw, kPa,-‘s-i 
DLCO, % predicted 
MVV, 1 min-’ 
MEP, cm water 
MIP, cm water 
Tlim, s 
Qds (% predicted) 
Hand grip strength, kgW 
Lean body mass (kg) 
Peak 902, 1 min-’ 
Peak 602, ml kg-‘min-’ 
Peak VO2, % predicted 
Work Capacity, watts 
Peak VC02, 1 min- ’ 
BS 
LS 
Controls n=20 As subjects n=20 
46.4 (12.2) 
13:7 
7:13 
169 (9.0) 
66.2 (13.7) 
106 (18.9) 
115 (21.7) 
103 (25.1) 
104 (15.3) 
2.3 (0.5) 
103 (19.9) 
133 (6.6) 
117-7 (32.9) 
90.3 (29.9) 
258 (106) 
95.0 (15.0) 
42.7 (9.9) 
57.9 (10.2) 
2.31 (2.4) 
33.1 (10.2) 
93 (9.7) 
148 (24.6) 
2.54 (2.0) 
6.7 (3.5) 
7.1 (3.2) 
46.5 (12.3) 
13:7 
9:ll 
167 (8.1) 
57.5 (11.3)* 
78 (12.0)* 
122 (38.6) 
110 (30.1) 
86 (15.3)* 
2.5 (0.4) 
98 (23.7) 
106 (7.4)* 
111.4 (37.7) 
Ill.4 (37.7) 
130 (116)* 
69.5 (22.9)* 
35.3 (11.7)* 
49.6 (11.4)* 
1.82 (2.6)* 
25.2 (9.9)* 
75 (10.6)* 
123 (21.3)* 
2.0 (3.1)* 
6.5 (3.7) 
8.7 (2.5) 
*Values are Mean (SD). P-eO.01. 
TABLE 2. Respiratory variables at rest and peak exercise in Ankylosing Spondylitis and controls 
Control n=20 AS n=20 
Rest Peak exericise Rest Peak exercise 
f, Breaths mitt-’ 
VT, 1 
VE, 1 
tcPO,, mmHg 
tcPO,, mmHg 
vC/h--vD/vT 
Aa?z, mHg 
VIE/VCO& 1 I- l 
BR, % 
14 (4) 30 (10) 
0.14 (0.2) 2.28 (0.95) 
5.74 (1.2) 68.1 (15.9) 
89 (8.2) 94 (10.1) 
37 (3.7) 41 (5.1) 
0.33 (0.09) 0.19 (0.05) 
12 (4.6) 14 (5.3) 
23.7 (4.5) 
49 (10.2) 
16 (3) 3s (12)* 
0.45 (0.2) 1.81 (0.83)* 
7.2 (2.1) 63.2 (18.9) 
88 (0.1) 91 (11.2) 
36 (3.9) 39 (4.9) 
0.35 (0.10) 0.22 (0.06) 
15 (5.2) 17 (6.0) 
26.8 (4.1)* 
40 (11.1) 
Values are Mean (SD). *P-co.01 
exercising complaining of leg fatigue. Leg fatigue scores P<O.Ol; respectively] were steeper in the AS group 
reported by AS subjects were higher than those reported by compared to controls. This indicates a higher intensity of 
control subjects at 8.7kO.3 and 7.1 kO.5, respectively breathing effort perceived among the AS subjects for 
(PcO.01). Mean breathlessness scores (BS) at peak exercise equivalent levels of work rate and oxygen uptake achieved. 
were comparable between the two groups. However, mean Table 2 shows the respiratory variables at rest and peak 
slopes of ABS/AWR [O-O54 (SD 0.1) vs. 0.043 (0.06), exercise. The ventilatory response (Vn/irCOz) on exertion 
P=O.O3] and ABS/AV02% rO.084 (0.18) vs. 0.045 (0.0.06) was higher in the AS subjects compared to controls 
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TABLE 3. Cardiocirculatory variables and peak exercise cardiac responses in ankylosing spondylitis (AS) and control 
subjects 
Controls As subjects 
Maximum HR, bts min-’ 
BP systolic, mmHg 
BP diastolic, mmHg 
HR/V02, bts 1-i 
Oxygen pulse, ml bt- ’ 
AT, 1 mini 
AT, % predicted VO2 max 
*Values are Mean (SD). P<O.Ol. 
161 (17.9) 153 (15.3) 
160 (19.2) 166 (18.9) 
81 (10.1) 83 (11.3) 
39.5 (4.9) 50.0 (5.8)* 
14.6 (2.9) 12.0 (3-l)* 
1.35 (0.32) 1.10 (0.26)* 
52 (5.0) 44 (5.1) 
TABLE 4. The individual influences of explanatory variables on peak VO2 in 20 ankylosing spondylitis (AS) subjects 
(“L:: 
MIP Tlim CR 
(2~) 
Hand grip LBM Age Wall-tragus TL 
(cm I-W) (4 (cm> (WV (ks) distance mobility 
r2 12 (%) 11.8 0 0 53.0 23.5 13.5 10.7 0 0 
F 4.29 4.21 0.49 0.25 22.16 8.35 4.9 3.87 0.67 0.07 
P-value 0.05 0.05 0.49 0.62 <O.OOl 0.008 0.03 0.06 0.42 0.79 
(26.8 + 1.1 and 23.7kO.9 l/l, respectively P=O.Ol) although 
breathing reserve (BR) remained adequate in both groups. 
The significantly smaller mean tidal volume and higher 
mean breathing frequency in the AS subjects compared to 
controls indicate the tendency of the AS subjects to reach 
higher levels of ventilation by shallower but more rapid 
breathing. There was no significant difference between 
indices of gas exchange (tcPO2, tcPCO2, Vr-,/Vr and Aa02 
gradient ) at rest and at peak exercise in the AS subjects 
compared to controls. Table 3 shows the cardiocirculatory 
responses to exercise. AS subjects achieved a mean 
maximum heart rate of 85% predicted maximum. The 
heart rate response (HR/VO,) on exertion was elevated in 
AS subjects compared to controls (50.0f 3.5 and 39.5f 
3.0 bts 1-i PcO.01). The AT (% predicted maximum V02) 
was significantly reduced in the AS group (44k2.1 and 
52 + 1.9%, respectively P< 0.01) although this is still within 
the normal predicted range. Blood pressure response to 
exercise was not significantly different in the two groups. 
RELATIONSHIP BETWEEN 
PHYSIOLOGICAL VARIABLES, 
BREATHLESSNESS AND EXERCISE 
PARAMETERS IN AS SUBJECTS 
Table f shows the relationship between aerobic capacity 
(peak V02) and explanatory variables in AS subjects. There 
was only weak association between peak 902 and VC 
(?=12%) and peak902 and MIP (?=11.8%). Respiratory 
muscle endurance was not significantly related to aerobic 
power either directly or with the addition of other variables. 
There was no direct association between aerobic power 
and chest expansion (CE) and the addition of other 
variables did not improve the total variance explained. 
The strongest relationship between aerobic power and 
physiological variables were those which measured periph- 
eral strength. Qds (r=0.75) and handgrip strength (r=0.47) 
accounted for 53% and 23.5% (?) of the total variance 
(P<O.OOl and P<O.Ol, respectively). Since Qds was the 
single variable which exhibited the strongest association 
with peak 902 (Fig. l), other variables were added to the 
regression model in a step-wise fashion in order to explain 
the largest amount of the variability in peak 902 in this 
patient group. The addition of LBM significantly improved 
the explained variance to 78.3%. The addition of any other 
variable did not improve the explained variability in peak 
VO,. There was no significant association between any lung 
function variable, respiratory or skeletal muscle strength 
and endurance and aerobic capacity in the control group. 
The best model explaining variability in peak VO, is as 
follows: 
VOz peak (1min-i) =0.378 + 0.011 Qds (N-m) 
+ 0.005 LBM (kg) 
(F = 44.2), P< 0.001,2=‘78.3%, residuals SD 0.29, 
n= 20) 
Discussion 
This study found that mild to moderate ankylosing 
spondylitis was associated with a reduced aerobic capacity 
on exercise testing but that this reduction in aerobic 
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FIG. 1. Linear regression of peak 90, on Qds in 20 ankylosing spondylitis (AS) subjects. Peak V02(ml kg-‘min-‘) = 14.7 
f0.10 Qds (N-m) [ adj.? 53.0%, F=22.16, P<O.OOl, n=20]. 
capacity was unrelated to the degree of the axial skeletal 
abnormality or respiratory muscle performance. Peripheral 
muscle factors, in particular, peripheral muscle strength 
and lean body mass, were most closely related to aerobic 
capacity in patients with mild to moderate ankylosing 
spondylitis. 
The findings of mild to moderate reductions in vital 
capacity and total lung capacity are in agreement with 
previous studies (l-6). The normal transfer factor for 
carbon monoxide found in the AS subjects also agrees with 
other studies (7,8). 
There was a reduced aerobic capacity in exercise testing 
in the present study which confirms earlier findings (8). 
Reduced ventilatory capacity was the aspect of pulmonary 
function most closely associated with exercise limitation 
although this association was weak. Previous authors have 
also found abnormalities of gas exchange on exercise 
testing in AS subjects. Thus Renzetti et aI. (30) observed 
an increased physiological dead space (VojVr) and mild 
arterial desaturation in 12 AS patients and postulated that 
the spondylitic process led to a relative decrease in 
ventilation in the upper part of the lung, whereas increased 
diaphragmatic excursions caused a relative increase in 
ventilation in the lower lung, regions leading to a widening 
of ventilation/perfusion ratios. Studies on regional ventila- 
tion in AS have shown conflicting results. Using Krypton 
81M washout, Parkin et al. (31) found no significant 
differences in regional ventilation between 27 AS and 18 
control subjects. In contrast, Stewart et al. (32) observed a 
reduction in inhaled xenon reaching the lung apices but 
normal xenon perfusion in nine AS subjects and suggested a 
relative impairment of apical ventilation in AS. It was 
suggested that this ventilation/perfusion abnormality con- 
tributes to inefficient gas exchange and reduced aerobic 
capacity in AS patients. In the present study although there 
is an impaired aerobic capacity in the AS subjects compared 
to the controls there is no evidence of gas exchange 
abnormalities at rest or during exercise, in AS subjects with 
no cardiac or pulmonary parenchymal disease. This is in 
agreement with the findings of Miller and Sproule (33). 
There was a raised ventilatory response (irn/VCOz) in the 
AS patients compared to controls with a more rapid 
shallow breathing response on exertion. This is similar to 
finding in other studies of patients with spinal deformity 
(34-37). Even with the reduction in vital capacity, AS 
patients had a similar breathing reserve at peak 90, 
compared to controls suggesting the utilization of the same 
proportion of their ventilatory capacity at peak exercise. 
Cardiac responses to exercise differed in the AS subjects 
compared to controls. AS subjects achieved the same 
maximal heart rate as normal subjects but at a reduced 
aerobic capacity suggesting a higher than normal heart rate 
response and a reduced stroke volume at equivalent work 
rates. It has previously been shown that a high heart rate 
response occurs when work is performed by a smaller 
muscle mass (38). The raised heart rate response and 
reduced aerobic capacity found in the AS subjects may 
therefore be a reflection of this reduced lean body mass. 
Martinez et al. (39) recently highlighted the limitation of 
cardiopulmonary exercise testing in separating cardiac 
limitation from deconditioning. The findings of normal 
blood pressure response, normal oxygen pulse and an 
anaerobic threshold which, although lower than the control 
group, is within the normal range does not suggest any 
significant cardiac or vascular limitation on exercise testing 
in the AS subjects. An analysis of physiological variables 
that might affect exercise tolerance showed that aerobic 
capacity in AS patients was most closely related to 
peripheral muscle function. Pulmonary impairment and 
the severity of chest restriction appeared to influence 
aerobic capacity only weakly and to the same degree, 
suggesting that chest restriction in AS may express its 
influence on aerobic capacity through a reduction in vital 
capacity. In a study by Kearon et al. (37) a reduced work 
capacity was unrelated to the severity or nature of the 
spinal deformity in idiopathic scoliosis, but was related to 
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the reduction in vital capacity. They suggested, however, 
that the relationships between spinal deformity and 
pulmonary impairment and of pulmonary impairment to 
disability are so variable in these patients that no direct 
relationship between deformity and disability could be 
identified. Previous authors have shown a relationship 
between the degree of spinal deformity and aerobic capacity 
(40-41). Chong et al. (40) reported a definite trend between 
the angle of scoliosis and peak oxygen consumption in 38 
subjects with spinal deformity. In the present study the weak 
association between the pulmonary impairment and degree 
of spinal abnormality may only reflect the mild to moderate 
status of the spinal deformity in this patient group. 
The present study emphasizes the importance of assessing 
peripheral muscle function when evaluating exercise intol- 
erance. The most striking difference between patients with 
AS and the control group was in the measurements of 
peripheral skeletal muscle strength and lean body mass 
which were significantly reduced compared to controls. 
Peripheral muscle impairment has also been implicated as a 
contributor to reduced exercise capacity in other cardio- 
respiratory disorders (37,42,43). In patients with idiopathic 
scoliosis (37) peripheral muscle function, particularly leg 
muscularity, had the dominant influence on work capacity. 
In children with cystic fibrosis muscularity, as well as the 
degree of airflow obstruction, has been shown to contribute 
to reduced aerobic capacity (42). Peripheral muscle strength 
has also been found to be related to exercise performance in 
chronic heart failure but not in normal subjects (44). This 
last finding is in keeping with the conclusions of a study by 
Killian et al. (45) who observed that symptoms of leg 
fatigue rather than dyspnoea were frequently limiting 
exercise in patients with mild to moderate COPD. This is 
similar to the present study, in that leg fatigue was scored 
more highly than dyspnoea during exercise in the patients 
with ankylosing spondylitis, and was the main reason for 
termination of exercise in these patents. In a study of 
exercise limitation in COPD by Gosselink et al. (46) 
isometric quadriceps force (QF) was significantly related 
to 90, max (r=0.55). This suggests that peripheral muscle 
function as well as lung function is an important 
determinant of exercise capacity in COPD. Our findings 
in patients with ankylosing spondylitis, who do not show 
any major impairment in pulmonary function, suggests that 
peripheral muscle function is the most important determi- 
nant of aerobic capacity in these patients. Reduced muscle 
function may be caused by loss of endurance, loss of 
strength of the muscle or both. In patients with COPD it is 
suggested that inactivity, hypoxaemia and malnourishment 
in combination lead to alterations in fibre type distribution, 
reduction in capillary density, decrease in mitochondrial 
population and ‘inertia’ in the oxidative machinery of 
peripheral muscles (46,47). If muscle oxidative metabolism 
reaches its limits owing to lack of oxygen delivery or 
inefficient utilization then the muscles will switch to 
anaerobic metabolism resulting in intra-muscular lactic 
acidosis which will contribute to reduced exercise capacity. 
In the present study, the anaerobic threshold on exertion 
was significantly reduced in ankylosing spondylitis com- 
pared to normal controls suggesting that similar mechan- 
isms of peripheral muscle impairment may be operative in 
these patients. A further explanation for the reduced 
aerobic capacity could be loss of muscle mass, resulting in 
a reduction in muscle strength, compromising its ability to 
overcome the load applied to the muscle during exercise. 
The relationship between aerobic capacity and the volume 
of muscle to do work is well recognised in healthy children 
and young adults (48,49). In addition, lean body mass has 
been shown to complement measures of pulmonary 
function in the prediction of disability in adults with 
pulmonary impairment (50,51). Previous studies in patients 
with idiopathic scoliosis (37), cystic fibrosis (42) and COPD 
(47) have demonstrated a negative influence of the 
reduction in lean body mass on exercise performance. A 
study by Palange et al. (47) has shown an inverse 
correlation between percent ideal body weight and %‘Oz 
time constant during moderate exercise demonstrating that 
in COPD patients, the decline in body mass parallels the 
impairment of muscle aerobic capacity. We have found that 
the inclusion of lean body mass (LBM) to the regression 
analysis with Qds significantly improved the explained 
variance. Lean body mass can be used as an index of muscle 
mass (52) and the metabolic demands of the muscles during 
exercise will decrease with a reduction in mass. Hence, 
LBM exerts a significance influence on peak 7j02. Thus 
impaired peripheral muscle strength and reduced muscle 
mass contribute to the reduced aerobic capacity in patents 
with ankylosing spondylitis which is similar to the findings 
in patients with other forms of cardio-respiratory disorders. 
This study shows that aerobic capacity is commonly 
reduced in patients with AS. Although a degree of 
restrictive defect is not uncommon, pulmonary impairment 
does not significantly limit aerobic capacity in this group of 
AS patients. This study suggests that peripheral muscle 
function is the most important determinant of exercise 
intolerance in mild to moderate AS patients. Diseases 
leading to spinal deformity vary from trivial to grossly 
deforming with respiratory failure and car pulmonale. In 
patients with more severe pulmonary or spinal deformity 
other factors, including pulmonary impairment, would be 
expected to play a greater role in exercise limitation. 
Previous studies, however, have shown that lung function 
and nutritional status were independent in advanced cystic 
fibrosis (42). In addition, Bjure et al. (53) have shown that 
cardiovascular and peripheral muscle training improved 
work capacity in patients with idiopathic scoliosis, despite 
moderately severe pulmonary impairment which remained 
unchanged. As Kearon et al. (37) have suggested, this 
emphasizes that peripheral muscle conditioning and their 
circulatory interaction are clinically important determi- 
nants of functional status in patients with spinal deformity. 
Peripheral muscle training has also been found to improve 
exercise tolerance in coronary artery disease (53) and 
COAD (54). Interactions aimed at improving peripheral 
muscle function in patients with ankylosing spondylitis 
would also be expected to improve exercise tolerance and 
reduce exertional symptoms. 
The reason for reduced peripheral muscle function in 
patients with ankylosing spondylitis is complex. Muscle 
weakness and fatigue may occur secondary to inadequate 
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muscle deconditioning. A possible explanation of this 
impaired muscle function in AS is the relative lack of 
physical activity consequent to the chronic nature of the 
disease. Cosmetics may play an important role, in that the 
deformed patients will not expose themselves in the usual 
sporting activities. In addition, altered transmission of 
stress through a deformed spine may lead to pain which 
limits activity. The findings of this study therefore suggest 
that a strategy to improve muscle function should be given 
priority in any rehabilitation/training programme in AS 
patients. 
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